Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026)
Alcon (ALC) recorded quarterly Liabilities and Shareholders Equity of $31.6 billion in Q1 2026, little changed quarter-over-quarter from $31.6 billion in Q4 2025.
Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Alcon's Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $31.6 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $31.6 billion; the TTM figure through Mar 2026 stood at $126.1 billion (up 39.43% YoY), while the FY2025 annual figure was $31.6 billion, up 3.98% from the prior year.
- Liabilities and Shareholders Equity was $31.6 billion for Q1 2026 at Alcon, roughly flat from $31.6 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $31.6 billion in Q1 2026 to a low of $27.7 billion in Q2 2022.
- Historically, Liabilities and Shareholders Equity has averaged $29.8 billion across 5 years, with a median of $29.6 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity fell 0.08% in 2022, then gained 5.66% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $29.2 billion in 2022, then climbed by 1.54% to $29.6 billion in 2023, then climbed by 2.48% to $30.3 billion in 2024, then increased by 3.98% to $31.6 billion in 2025, then rose by 0.2% to $31.6 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $31.6 billion (Q1 2026), $31.6 billion (Q4 2025), and $31.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Alcon | 25,681.50 | -1.66 Bn | 1.53 Bn | 31.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.62 Bn |
| Dec 31, 2025 | 31.56 Bn |
| Sep 30, 2025 | 31.52 Bn |
| Jun 30, 2025 | 31.39 Bn |
| Dec 31, 2024 | 30.35 Bn |
| Sep 30, 2024 | 30.36 Bn |
| Jun 30, 2024 | 29.72 Bn |
| Mar 31, 2024 | 29.57 Bn |
| Dec 31, 2023 | 29.61 Bn |
| Sep 30, 2023 | 29.37 Bn |
| Jun 30, 2023 | 29.21 Bn |
| Mar 31, 2023 | 29.29 Bn |
| Dec 31, 2022 | 29.17 Bn |
| Sep 30, 2022 | 27.80 Bn |
| Jun 30, 2022 | 27.73 Bn |
| Mar 31, 2022 | 27.79 Bn |
| Dec 31, 2021 | 28.00 Bn |
| Sep 30, 2021 | 27.80 Bn |
| Jun 30, 2021 | 27.75 Bn |
| Mar 31, 2021 | 27.37 Bn |